352 related articles for article (PubMed ID: 7129012)
1. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
Hisamatsu T; Uchida S
Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
4. A new nitrosourea derivative TA-077, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea. I. Comparative study on antitumor activity.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 9(3):134-9. PubMed ID: 6218931
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors.
Shimizu F; Arakawa M
Gan; 1978 Aug; 69(4):545-8. PubMed ID: 710804
[TBL] [Abstract][Full Text] [Related]
6. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
7. A comparison of a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea with various antitumor agents with respect to therapeutic ratios in L1210 leukemia systems.
Fujimoto S; Ogawa M
J Pharmacobiodyn; 1987 Jul; 10(7):341-5. PubMed ID: 3694427
[TBL] [Abstract][Full Text] [Related]
8. Letter: Antitumor activities of 3-(methyl-alpha-D-glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea.
Iwasaki M; Okawa H; Ninomiya K; Sekine J; Nagamatsu Y
Gan; 1975 Jun; 66(3):347-8. PubMed ID: 1181236
[No Abstract] [Full Text] [Related]
9. Toxicological study on a new nitrosourea derivative, 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea.
Fujimoto S; Ogawa M
Jpn J Cancer Res; 1985 Jul; 76(7):651-6. PubMed ID: 3928562
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
[TBL] [Abstract][Full Text] [Related]
11. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
[No Abstract] [Full Text] [Related]
12. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3-[4-amino-2-methyl-5-pyrimidinyl)ethyl[-1(2-chloroethyl)-1-nitrosourea hydrochloride on lymphoid leukemia L-1210.
Shimizu F; Arakawa M
Gan; 1975 Apr; 66(2):149-54. PubMed ID: 1150007
[TBL] [Abstract][Full Text] [Related]
15. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M; Sakurai Y
Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
[No Abstract] [Full Text] [Related]
16. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
Mazerska Z; Lukowicz J; Konopa J
Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
[TBL] [Abstract][Full Text] [Related]
17. [Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].
Sekido S; Ninomiya K; Araki T; Ueno M; Kinbara M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1492-500. PubMed ID: 6234861
[TBL] [Abstract][Full Text] [Related]
18. A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
Tsujihara K; Ozeki M; Morikawa T; Kawamori M; Akaike Y; Arai Y
J Med Chem; 1982 Apr; 25(4):441-6. PubMed ID: 7069723
[TBL] [Abstract][Full Text] [Related]
19. Activity of 10-chloro-5-(2-dimethylaminoethyl)-7H-indolo [2,3-c]-quinolin-6(5H)-one hydrochloride against experimental tumors in mice and rats.
Grunberg E; Kramer MJ; Buck M; Trown PW
Chemotherapy; 1978; 24(2):77-80. PubMed ID: 579626
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructral changes induced by 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea in L1210 lymphocytic leukemia cells in mice.
Fukuda K; Shindo H; Shimizu F; Arakawa M; Mizuhira V
Cancer Res; 1980 Jan; 40(1):133-8. PubMed ID: 7349893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
